Pechmann, Astrid
König, Kirsten
Bernert, Günther
Schachtrup, Kristina
Schara, Ulrike
Schorling, David
Schwersenz, Inge
Stein, Sabine
Tassoni, Adrian
Vogt, Sibylle
Walter, Maggie C.
Lochmüller, Hanns
Kirschner, Janbernd
Funding for this research was provided by:
Biogen (Not applicable)
Article History
Received: 20 November 2018
Accepted: 8 January 2019
First Online: 21 January 2019
Ethics approval
: Of the central ethics committee has been obtained (Ethics Committee of the University of Freiburg, Germany (EK 56/18)).
: not applicable
: JK received research funding and/or compensation for presentations and consultancy from Avexis, Biogen, Ionis Pharmaceuticals, Novartis, and Roche. AP, SS, and SV received compensations for presentations and training activities from Biogen. MCW received research funding and/or compensation for presentations and consultancy from Avexis, Biogen, Novartis, and Roche. US received compensation for presentations and consultancy from Avexis, Biogen, Ionis Pharmaceuticals, Novartis, and Roche. GB received compensation for presentations and consultancy from Biogen. DS participated in sponsored workshops by Biogen.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.